Amneal Pharmaceuticals (AMRX) Treasury Shares (2018 - 2025)

Amneal Pharmaceuticals' Treasury Shares history runs 8 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• On a quarterly basis, Treasury Shares fell 87.36% year-over-year to $2.2 million in Q4 2025; TTM through Dec 2025 was $2.2 million, a 87.36% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 87.36% from the prior year.
• Treasury Shares retreated to $2.2 million in Q4 2025 per AMRX's latest filing, from $17.6 million in the prior quarter.
• Across five years, Treasury Shares topped out at $17.9 million in Q4 2022 and bottomed at $2.2 million in Q4 2025.
• The 5-year median for Treasury Shares is $17.5 million (2023), against an average of $13.7 million.
• Across the five-year window, Treasury Shares jumped 44.36% in 2021 and sank 87.36% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $13.2 million in 2021, then surged by 35.99% to $17.9 million in 2022, then dropped by 2.64% to $17.5 million in 2023, then increased by 0.7% to $17.6 million in 2024, then sank by 87.36% to $2.2 million in 2025.
• Per Business Quant, the three latest AMRX Treasury Shares figures stand at $2.2 million (Q4 2025), $17.6 million (Q4 2024), and $17.5 million (Q4 2023).